Coraza, Marino A.
HRN: 02-98-69 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/27/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/27/2024
10/03/2024
IV
2.25g
Q8h
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes